on GENFIT (EPA:GNFT)
Half-yearly report on GENFIT's liquidity contract with CIC
On January 13, 2025, GENFIT, a listed biopharmaceutical company, published its half-yearly report for its liquidity agreement with Crédit Industriel et Commercial (CIC). This agreement, aimed at supporting the liquidity of GENFIT shares, recorded a liquidity account comprising 207,500 shares and €353,960.14 as of December 31, 2024.
In the second half of 2024, a total of 2,075,591 shares were purchased for EUR 8,893,798.52 while 1,999,091 shares were sold for EUR 8,546,873.15. The transactions executed amounted to 2,752 for purchase and 2,582 for sale.
At the signing of the contract, the liquidity account consisted of 27,911 shares and 769,849.43 euros, highlighting increased activity over this period. These data demonstrate GENFIT's commitment to maintaining the liquidity of its shares on the market.
R. P.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all GENFIT news